255 related articles for article (PubMed ID: 27888602)
1. A Glycovariant of Human CD44 is Characteristically Expressed on Human Mesenchymal Stem Cells.
Pachón-Peña G; Donnelly C; Ruiz-Cañada C; Katz A; Fernández-Veledo S; Vendrell J; Sackstein R
Stem Cells; 2017 Apr; 35(4):1080-1092. PubMed ID: 27888602
[TBL] [Abstract][Full Text] [Related]
2. Production via good manufacturing practice of exofucosylated human mesenchymal stromal cells for clinical applications.
López-Lucas MD; Pachón-Peña G; García-Hernández AM; Parrado A; Sánchez-Salinas D; García-Bernal D; Algueró MDC; Martinez FI; Blanquer M; Cabañas-Perianes V; Molina-Molina M; Asín-Aguilar C; Moraleda JM; Sackstein R
Cytotherapy; 2018 Sep; 20(9):1110-1123. PubMed ID: 30170815
[TBL] [Abstract][Full Text] [Related]
3. Glycoengineering of E-Selectin Ligands by Intracellular versus Extracellular Fucosylation Differentially Affects Osteotropism of Human Mesenchymal Stem Cells.
Dykstra B; Lee J; Mortensen LJ; Yu H; Wu ZL; Lin CP; Rossi DJ; Sackstein R
Stem Cells; 2016 Oct; 34(10):2501-2511. PubMed ID: 27335219
[TBL] [Abstract][Full Text] [Related]
4. HCELL Expression on Murine MSC Licenses Pancreatotropism and Confers Durable Reversal of Autoimmune Diabetes in NOD Mice.
Abdi R; Moore R; Sakai S; Donnelly CB; Mounayar M; Sackstein R
Stem Cells; 2015 May; 33(5):1523-31. PubMed ID: 25641589
[TBL] [Abstract][Full Text] [Related]
5. Fulfilling Koch's postulates in glycoscience: HCELL, GPS and translational glycobiology.
Sackstein R
Glycobiology; 2016 Jun; 26(6):560-70. PubMed ID: 26933169
[TBL] [Abstract][Full Text] [Related]
6. CD44 fucosylation on mesenchymal stem cell enhances homing and macrophage polarization in ischemic kidney injury.
Chou KJ; Lee PT; Chen CL; Hsu CY; Huang WC; Huang CW; Fang HC
Exp Cell Res; 2017 Jan; 350(1):91-102. PubMed ID: 27871849
[TBL] [Abstract][Full Text] [Related]
7. Cell-Specific Variation in E-Selectin Ligand Expression among Human Peripheral Blood Mononuclear Cells: Implications for Immunosurveillance and Pathobiology.
Silva M; Fung RKF; Donnelly CB; Videira PA; Sackstein R
J Immunol; 2017 May; 198(9):3576-3587. PubMed ID: 28330896
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone.
Sackstein R; Merzaban JS; Cain DW; Dagia NM; Spencer JA; Lin CP; Wohlgemuth R
Nat Med; 2008 Feb; 14(2):181-7. PubMed ID: 18193058
[TBL] [Abstract][Full Text] [Related]
9. Enforced hematopoietic cell E- and L-selectin ligand (HCELL) expression primes transendothelial migration of human mesenchymal stem cells.
Thankamony SP; Sackstein R
Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2258-63. PubMed ID: 21257905
[TBL] [Abstract][Full Text] [Related]
10. Glycoengineering of HCELL, the human bone marrow homing receptor: sweetly programming cell migration.
Sackstein R
Ann Biomed Eng; 2012 Apr; 40(4):766-76. PubMed ID: 22068886
[TBL] [Abstract][Full Text] [Related]
11. CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.
Shirure VS; Liu T; Delgadillo LF; Cuckler CM; Tees DF; Benencia F; Goetz DJ; Burdick MM
Am J Physiol Cell Physiol; 2015 Jan; 308(1):C68-78. PubMed ID: 25339657
[TBL] [Abstract][Full Text] [Related]
12. Glycosyltransferase-programmed stereosubstitution (GPS) to create HCELL: engineering a roadmap for cell migration.
Sackstein R
Immunol Rev; 2009 Jul; 230(1):51-74. PubMed ID: 19594629
[TBL] [Abstract][Full Text] [Related]
13. differential L-selectin binding activities of human hematopoietic cell L-selectin ligands, HCELL and PSGL-1.
Dimitroff CJ; Lee JY; Schor KS; Sandmaier BM; Sackstein R
J Biol Chem; 2001 Dec; 276(50):47623-31. PubMed ID: 11591704
[TBL] [Abstract][Full Text] [Related]
14. [The effects of CD44 fucosylation on fluid adhesion force of rabbit bone marrow mesenchymal stem cells].
Xiao F; Jiao J; Huang Y; Xu H; Zuo W; Wang J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2018 Jan; 32(1):99-103. PubMed ID: 29806373
[TBL] [Abstract][Full Text] [Related]
15. A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancer.
Carrascal MA; Silva M; Ferreira JA; Azevedo R; Ferreira D; Silva AMN; Ligeiro D; Santos LL; Sackstein R; Videira PA
Biochim Biophys Acta Gen Subj; 2018 Sep; 1862(9):2069-2080. PubMed ID: 29777742
[TBL] [Abstract][Full Text] [Related]
16. Glycoengineering of chimeric antigen receptor (CAR) T-cells to enforce E-selectin binding.
Mondal N; Silva M; Castano AP; Maus MV; Sackstein R
J Biol Chem; 2019 Nov; 294(48):18465-18474. PubMed ID: 31628196
[TBL] [Abstract][Full Text] [Related]
17. The biology of CD44 and HCELL in hematopoiesis: the 'step 2-bypass pathway' and other emerging perspectives.
Sackstein R
Curr Opin Hematol; 2011 Jul; 18(4):239-48. PubMed ID: 21546828
[TBL] [Abstract][Full Text] [Related]
18. Ligation of the CD44 Glycoform HCELL on Culture-Expanded Human Monocyte-Derived Dendritic Cells Programs Transendothelial Migration.
Videira PA; Silva M; Martin KC; Sackstein R
J Immunol; 2018 Aug; 201(3):1030-1043. PubMed ID: 29941663
[TBL] [Abstract][Full Text] [Related]
19. Discordant expression of selectin ligands and sialyl Lewis x-related epitopes on murine myeloid cells.
Kobzdej MM; Leppänen A; Ramachandran V; Cummings RD; McEver RP
Blood; 2002 Dec; 100(13):4485-94. PubMed ID: 12393554
[TBL] [Abstract][Full Text] [Related]
20. Using Eukaryotic Expression Systems to Generate Human α1,3-Fucosyltransferases That Effectively Create Selectin-Binding Glycans on Stem Cells.
Al-Amoodi AS; Sakashita K; Ali AJ; Zhou R; Lee JM; Tehseen M; Li M; Belmonte JCI; Kusakabe T; Merzaban JS
Biochemistry; 2020 Oct; 59(39):3757-3771. PubMed ID: 32901486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
